|
|
|
|
|
| Summary |
Issues detailed requirements for the manufacturing and control of selected biologicals. New requirements are provided for Vi polysaccharide typhoid vaccine, and for live combined measles, mumps and rubella vaccines. Revised requirements for the collection, processing and quality control of blood, blood components and plasma derivatives are also presented, with particular attention given to the extreme care needed during manufacture to ensure that these products are free from infectious viruses, including HIV and hepatitis B virus. The book concludes with amendments to the requirements for three rabies vaccines.
- Requirements for Vi polysaccharide typhoid vaccine
- Requirements for the collection, processing and quality control of blood components and plasma derivatives (revised 1992)
- Requirements for measles, mumps and rubella vaccines and combined vaccine (live)
- Requirements for rabies vaccine for human use (amendment 1992)
- Requirements for rabies vaccine (inactivated) for human use produced in continuous cell lines (amendment 1992)
- Requirements for rabies vaccine for veterinary use (amendment 1992)
|
|
|
